Meridian Bioscience, Inc. (NASDAQ:VIVO) is an integrated life science company. The Company is engaged in developing, manufacturing, selling and distribution of clinical diagnostic test kits, for certain gastrointestinal, viral, respiratory and parasitic infectious diseases; the manufacture and distribution of bulk antigens, antibodies, polymerase chain reaction (PCR)/ quantitative polymerase chain reaction (qPCR) reagents, nucleotides, competent cells and bioresearch reagents used by researchers and other diagnostic manufacturers, … Continue reading Diagnostic Substances: Meridian Bioscience (NASDAQ:VIVO), Vermillion (NASDAQ:VRML), Atossa Genetics Inc (NASDAQ:ATOS), IDEXX Laboratories (NASDAQ:IDXX)